Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo

BACKGROUND: In patients with major depressive disorder (MDD), antidepressant response and remission rates are low, highlighting the need for new treatment approaches. Recently, the abundant literature linking inflammatory processes and depressive symptoms have led to the hypothesis that selecting tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Fourrier, Célia, Sampson, Emma, Mills, Natalie T., Baune, Bernhard T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102899/
https://www.ncbi.nlm.nih.gov/pubmed/30126458
http://dx.doi.org/10.1186/s13063-018-2829-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102899/
https://www.ncbi.nlm.nih.gov/pubmed/30126458
http://dx.doi.org/10.1186/s13063-018-2829-7

Ejemplares similares